Aramark vs McDonalds
ARMK and MCD side by side, both in eating and drinking places. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARMK and MCD compare
Aramark is the larger company, worth 73055 times as much as McDonalds ($14.3B against $196K).
Aramark grew revenue faster over the last twelve months (11.0% versus 5.8% for McDonalds).
McDonalds keeps more of each dollar of sales as profit, with a net margin of 32.4% compared with 1.9% at Aramark.
Both pay dividends: Aramark yields 0.89% and McDonalds 2.7%.
McDonalds scores higher on the StockData Score (16 against 11 for Aramark), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARMK | MCD |
|---|---|---|
| Size and price | ||
| Market cap | $14.3B | $196K |
| Share price | $54.22 | $274.80 |
| Change, 1 year | 43.4% | −8.1% |
| Change, 5 years | 48.6% | 9.1% |
| Beta (5Y) | 0.91 | 0.45 |
| Employees | 278K | 150K |
| StockData Score | ||
| Total score | 11 | 16 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 2 | 4 (better) |
| Health score | 2 | 3 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 37.9× | – |
| P/S | 0.7× | 0.0× (better) |
| P/B | 4.2× | – |
| EV/EBITDA | 14.3× | 2.9× (better) |
| P/FCF | 33.0× | 0.0× (better) |
| PEG | 2.15 | – |
| FCF yield | 3.0% | 3828630% (better) |
| Fair value | $46.21 | $141854000.00 |
| Margin of safety | −17.3% | 100.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.0% (better) | 5.8% |
| Revenue growth, 5Y average | 7.6% (better) | 7.0% |
| Net income growth (TTM) | 5.9% | 6.9% (better) |
| EPS growth (TTM) | 5.9% | – |
| EPS growth, 5Y average | – | 13.6% |
| Profitability | ||
| Gross margin | 8.5% | – |
| Operating margin | 4.4% | 46.9% (better) |
| Net margin | 1.9% | 32.4% (better) |
| FCF margin | 2.2% | 27.0% (better) |
| Return on equity | 11.8% | – |
| Return on invested capital | 7.2% | 27.5% (better) |
| Financial health | ||
| Debt / equity | 1.81 | – |
| Net debt / EBITDA | 4.05 | 2.86 (better) |
| Interest coverage | – | 8.0× |
| Current ratio | 1.28 (better) | 1.23 |
| Altman Z-score | 2.58 | 2.87 (better) |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 0.89% | 2.7% (better) |
| Payout ratio | 31.9% | 58.7% |
| Years of dividend growth | 1 | 16 (better) |
| Dividend growth, 5Y average | −0.93% | 7.3% (better) |
| Buyback yield | 0.33% | 1198010% (better) |
| Shareholder yield | 1.2% | 1198010% (better) |
| Ownership | ||
| Held by institutions | 98.8% | 74.6% |
| Held by insiders | 0.77% | 0.03% |
| Insider net buying, 12 months | −$5.3M (better) | −$30.3M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 2.9% | 1.6% |
Go deeper
- ARMK stock overview
- ARMK income statement
- ARMK valuation and score
- MCD stock overview
- MCD income statement
- MCD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.